LLYNYSEPharmaceutical PreparationsFiscal year ends December 31

ELI LILLY & Co

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$1240.34−16.69 (-1.33%)

Close on Oct 19, 2026

Market cap: $1.11T
P/E (TTM): 41.6
Dividend yield: 0.50%

ELI LILLY & Co income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	65,179	45,043	34,124	28,541	28,318	24,540	22,320	21,493	19,974	21,222	19,959	19,616	23,113	22,603	24,287	23,076	21,836	20,372	18,634
Cost of Revenue	11,052	8,418	7,082	6,630	7,313	5,483	4,721	4,682	4,448	5,710	5,037	4,933	4,908	4,797	5,068	4,366	4,247	4,377	4,249
Gross Profit	54,127	36,625	27,042	21,912	21,006	19,057	17,598	16,812	15,526	15,512	14,922	14,683	18,205	17,807	19,219	18,710	17,589	15,995	14,385
Research & Development	13,337	10,991	9,313	7,191	6,931	5,976	5,595	5,051	5,096	5,310	4,796	4,734	5,531	5,278	5,021	4,884	4,327	3,841	3,487
Selling, General & Admin	11,094	8,594	7,404	6,440	6,432	6,121	6,214	5,975	5,982	6,528	6,533	6,621	7,126	7,514	7,880	7,053	6,893	6,626	6,095
Advertising Expenses	2,900	1,400	1,100	967	1,240	1,100	1,100	900	700	–	–	–	–	–	–	–	–	–	–
Interest Expense	895	781	486	332	340	360	401	243	225	185	161	149	160	178	186	186	261	-228	–
Interest & Investment Income	–	175	174	63	25	33	80	159	166	109	87	121	120	105	80	52	75	-211	–
Other Non-Operating Income	-571	-219	97	-321	-202	1,172	292	146	302	113	101	341	519	674	-179	-5.00	-230	26	122
Merger & Restructuring Charges	484	861	68	245	316	131	576	267	1,332	383	368	469	121	281	401	192	693	1,974	303
Asset Impairment Charges	0	0	0	0	0	0	0	0	284	256	227	243	30	207	150	50	364	363	–
Gain (Loss) on Investments	–	-50	-24	-420	178	1,439	403	27	–	–	–	195	41	67	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	0	0	3,681	0	0	–	–	–	–	–	–	–	–	–	–
Pretax Income	25,731	12,680	6,554	6,806	6,156	7,230	5,266	3,680	2,305	3,374	2,790	3,000	5,889	5,408	5,350	6,767	5,358	-1,308	3,877
Income Tax Expense	5,091	2,090	1,314	562	574	1,036	628	530	2,391	636	382	610	1,205	1,320	1,002	1,456	1,029	764	924
Income from Continuing Operations	–	–	–	–	5,582	6,194	4,638	3,151	-86	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	–	–	0	0	3,681	81	-118	–	–	–	–	–	–	–	–	–	–
Net Income	20,640	10,590	5,240	6,245	5,582	6,194	8,318	3,232	-204	2,738	2,408	2,391	4,685	4,089	4,348	5,070	4,329	-2,072	2,953
Net Income to Common	–	–	–	–	–	–	–	–	–	–	–	–	–	4,089	4,348	5,070	4,329	-2,072	–
EPS (Basic)(per share)	23.00	11.76	5.82	6.93	6.15	6.82	8.93	3.14	-0.19	2.59	2.27	2.23	4.33	3.67	3.90	4.58	3.94	-1.89	–
EPS (Diluted)(per share)	22.95	11.71	5.80	6.90	6.12	6.79	8.89	3.13	-0.19	2.58	2.26	2.23	4.32	3.66	3.90	4.58	3.94	-1.89	–
Shares Outstanding (Basic, Weighted)(shares)	897	901	900	902	907	908	931	1,028	1,052	1,058	1,062	1,070	1,081	1,113	1,114	1,106	1,098	1,094	–
Shares Outstanding (Diluted, Weighted)(shares)	899	904	903	905	912	913	936	1,034	1,052	1,062	1,066	1,074	1,085	1,117	1,114	1,106	1,098	1,094	–
Dividend per Share(per share)	6.23	5.40	4.69	4.07	3.53	3.07	2.68	2.33	2.12	2.05	–	–	–	–	1.96	1.96	1.96	1.90	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 83.4%
Operating margin: –
Net margin: 33.5%
Return on equity, FY2025: 101.2%

Financial strength

Current ratio: 1.35
Debt to equity: 1.62
Debt to assets: 38.6%
Cash to current liabilities: 18.7%

Valuation

P/E ratio: 41.6
Price to sales: 13.91
Price to book: 32.72
Dividend yield: 0.50%